Nevro Profit Margin

Nevro (NVRO) currently reports a profit margin of -27.77% as of December 2024. That compares with -21.69% in the prior-year period — down 28.0% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Nevro's profit margin history and peer comparisons.

Nevro's profit margin decreased from -21.69% to -27.77% — a 28.0% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nevro's profit margin of -27.77% is lower than the Healthcare sector average of 13.89%. That is roughly 300.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Nevro's current -27.77% should be judged against Healthcare norms (sector average: 13.89%) and against NVRO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -27.77%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Nevro, and consider following NVRO for alerts when major investors trade the stock.